๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Medroxyprogesterone- and megestrol acetate plasma levels after simultaneous oral administration in cancer patients

โœ Scribed by Camaggi, CM; Strocchi, E; Carisi, P; Biagi, S; Zamagni, C; Cacciari, N; Martoni, A; Pannuti, F

Book ID
123455513
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
168 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Medroxyprogesterone acetate (MAP) plasma
Medroxyprogesterone acetate (MAP) plasma levels after simultaneous oral and intramuscular administration in cancer patients
โœ Franco Pannuti; Carlo Maurizio Camaggi; Elena Strocchi; Michele Giovannini; Nadi ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Springer ๐ŸŒ English โš– 141 KB

After simultaneous administration of medroxyprogesterone acetate (MAP) 1,000 mg PO and 1,000 mg IM to ten cancer patients, we observed mean plasma MAP profiles that could be exactly superimposed on the two absorption/decay curves obtained after administration of single doses IM or PO. Treatment with

Medroxyprogesterone acetate (MAP) plasma
Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients
โœ Carlo Maurizio Camaggi; Elena Strocchi; Michele Giovannini; Bruna Angelelli; Bar ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› Springer ๐ŸŒ English โš– 352 KB

Medroxyprogesterone acetate plasma levels were measured in advanced cancer patients after multiple PO or IM administration (500, 1000, 2000, 3000, 4000, and 5000 mg/day PO and 500, 1000, 2000 mg/day IM for 30 days). After PO administration, the plasma concentration rises quickly and plateau level is